Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD


Primary Symbol: V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by mercedesmanon Jun 01, 2022 3:24pm
164 Views
Post# 34724308

RE:Good endorsement from Dr. Jerome Adams - Antibody tests

RE:Good endorsement from Dr. Jerome Adams - Antibody tests


The issue seems to be that the FDA (for now) is worried that Antibody tests might somehow discourage vaccinations, by giving people a false sense of protection when they receive an objective measure of antibody protection (that arguably can be subjective in that the interpretation of results may differ from person to person).

As someone who has educated himself on the science of antibody tests, I worry that the opposite problem may have been created by teh FDA in their latest stance. Right now, sans antibody tests, people are ASSUMING that they have antibody protection based on having had a prior infection or having had vaccinations. However we all know that those protections wane over time, and the assumption that you are "safe", at some point become invalid for every person in time.

Continual vaccinations become the only means of protection - whether warranted or not.

There needs to be some measure of protection (however vague) ...versus nothing at all.
Especially for the immunocompromised, the elderly, and for those health conscious individuals that understand that measurements are guides only and give you probablitlies of protection.

For now, we are all being painted with the "dumb brush"  (i.e some knowledge is dangerous to some, and may give some a "false sense" of security  - so lets keep everyone in the dark, and "hope" that they continue to get vaccinations - with whatever inherent  or unknown risks are associated with ongoing or over-vaccintion)

MM

<< Previous
Bullboard Posts
Next >>